vimarsana.com

Page 20 - ஷார்துள் அமர்சந்த் மங்கல்தாஸ் இணை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with . Centrient PharmaceuticalsFebruary 15, 2021 GMT Rotterdam, the Netherlands, February 15th, 2021, Feb. 15, 2021 (GLOBE NEWSWIRE) Further strengthens Centrient Pharmaceuticals’ position as the global business-to-business industry leader in beta-lactam antibiotics Broadens Centrient Pharmaceuticals’ product portfolio with sterile injectable Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin finished dosage forms, able to further meet the needs of customers in these segments and become a preferred partner for customers Brings in-house manufacturing capabilities for high-quality sterile antibiotic powder injectable finished dosage forms with two US FDA-approved production lines

Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms

Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms Further strengthens Centrient Pharmaceuticals position as the global business-to-business industry leader in beta-lactam antibiotics Broadens Centrient Pharmaceuticals product portfolio with sterile injectable Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin finished dosage forms, able to further meet the needs of customers in these segments and become a preferred partner for customers Brings in-house manufacturing capabilities for high-quality sterile antibiotic powder injectable finished dosage forms with two US FDA-approved production lines Centrient Pharmaceuticals ( Centrient ), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals , today announced the signing of an agreement for the acquisition of Astral SteriTech Private Limited ( Astral SteriTech ), a

ArcelorMittal Case: HC dismisses 2 Ruia Cos plea against ruling to deposit ₹82 cr

ArcelorMittal Case: HC dismisses 2 Ruia Cos’ plea against ruling to deposit ₹82 cr SECTIONS Share Synopsis In the case, the two firms, Essar House and Essar Services India, had received ₹35 crore and ₹47 crore, respectively, from Essar Steel as security deposit for office space and services. Agencies The December 10 order directed the Ruias to deposit ₹82 crore within eight weeks in the court as security in two separate arbitration suits filed by ArcelorMittal Nippon Steel India. Mumbai: The Bombay High Court dismissed a plea filed by two Ruias-owned companies that challenged the single bench ruling asking them to deposit ₹82 crore in the court as security in two separate arbitration suits filed by ArcelorMittal Nippon Steel India (formerly Essar Steel).

FDI cap hike to raise insurance penetration, help attract overseas funds: Experts

FDI cap hike to raise insurance penetration, help attract overseas funds: Experts SECTIONS Last Updated: Feb 07, 2021, 01:06 PM IST Share Synopsis The proposed increase in FDI would also likely result in increased value for customers by way of more product options at reduced costs, he said. Getty Images New Delhi: Implementation of the Budget proposal to raise the foreign direct investment (FDI) limit in the insurance sector to 74 per cent will help attract overseas capital and enhance insurance penetration in the country, according to experts. Deloitte India Partner and Financial Services Industry Leader Sanjoy Datta said the announcement to raise the FDI cap in the sector was a much-awaited move by the government. It is in direct recognition of the requirement for significant capital inflows to provide adequate levels of insurance cover to the population, he added.

Sabyasachi: Fashion s crouching tiger, hidden dragon

Sabyasachi: Fashion’s crouching tiger, hidden dragon Namrata Zakaria Small The biggest acquisition of an Indian fashion brand between ABFRL and designer Sabyasachi – decoded Just a couple of years ago, Sabyasachi told me about a lady who came up to him at Bhubaneswar airport and touched his feet. She said her husband came into great wealth copying the designer’s fashions and so she had also placed his photograph with her assortment of deities at the temple in her home. This story is a great signifier of the might the designer wields in the fashion (and, by extension, apparel) business. Hopefully, this story was also a consideration when the Aditya Birla Fashion and Retail Limited (ABFRL) group announced they were acquiring 51 per cent stake in his business for Rs 398 crore.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.